Form 4: Valens Semiconductor Director Trades VLN Shares

Valens Semiconductor Ltd. director Adi Yarel-Toledano reported transactions involving ordinary shares and stock options, executed under a Rule 10b5-1 trading plan.

Summary

• Adi Yarel-Toledano, a Director at Valens Semiconductor Ltd. (VLN), has filed a Form 4 detailing transactions involving ordinary shares and stock options.
• These transactions occurred on May 28, 2026, and May 29, 2026.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on December 1, 2025, which is intended to satisfy affirmative defense conditions for the purchase or sale of equity securities.
• On May 28, 2026, 5,100 ordinary shares were acquired upon exercise of stock options at $2.39 per share, and 5,100 ordinary shares were sold at a weighted average price of $3.50.
• On May 29, 2026, 17,225 ordinary shares were acquired upon exercise of stock options at $2.39 per share, and 17,225 ordinary shares were sold at a weighted average price of $3.32.
• Following these transactions, the reporting person beneficially owns 181,478 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves director sales, the execution under a Rule 10b5-1 plan mitigates negative sentiment, and the continued ownership of a substantial number of shares suggests ongoing confidence.

Positives

• The transactions were conducted under a pre-established Rule 10b5-1 trading plan, indicating a structured and planned approach to share disposition.
• The acquisition of shares upon exercise of stock options suggests potential alignment with employee or director compensation plans.
• The reporting person continues to hold a significant number of shares (181,478) after the reported sales.

Negatives

• The filing reports the sale of a substantial number of ordinary shares (5,100 on May 28 and 17,225 on May 29), which could be interpreted as a reduction in the director's direct stake.
• The sales occurred at prices higher than the exercise price of the options, indicating a profit-taking scenario.

Risks

• The sale of shares by a director, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, potentially impacting investor sentiment.
• The weighted average sale price for May 29, 2026, was $3.32, which is lower than the sale price on May 28, 2026 ($3.50), though this could be due to market fluctuations or the specific execution of the plan.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance regarding future company performance. It solely reports past transactions by a director.

Management Comments

• The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.
• The reporting person undertakes to provide full information regarding the number of shares and prices at which the transaction was effectuated, upon request.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales by directors, are closely watched by investors. The use of a Rule 10b5-1 plan is a common strategy to mitigate concerns about insider trading, allowing for pre-scheduled sales without implying adverse non-public information. However, the volume and timing of such sales can still influence market perception.

Stakeholder Impact

• Shareholders: May observe the director's share sales and consider the implications for stock price and company confidence, though the 10b5-1 plan provides some reassurance.
• Employees: May view the director's stock option exercises and sales as part of standard compensation and liquidity management.
• Management: The transactions are executed by a director, indicating a standard process for executive share management.

Next Steps

• The reporting person may continue to execute transactions under the Rule 10b5-1 plan.
• The company may provide further updates on insider transactions as they occur.

Key Dates

Keywords

Valens Semiconductor, VLN, Form 4, Insider Trading, Stock Options, Rule 10b5-1, Director Transactions, Share Sales, Beneficial Ownership